{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:47:19Z","timestamp":1791928039434,"version":"4.3.4"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000133","name":"AHRQ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.gtc.2021.02.010","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T10:45:11Z","timestamp":1621507511000},"page":"323-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea"],"prefix":"10.1016","volume":"50","author":[{"given":"Cyb\u00e9le Lara R.","family":"Abad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasia","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gtc.2021.02.010_bib1","first-page":"491","article-title":"Antibiotic associated diarrhea in children","volume":"46","author":"Alam","year":"2009","journal-title":"Indian Pediatr"},{"issue":"11","key":"10.1016\/j.gtc.2021.02.010_bib2","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.3748\/wjg.v22.i11.3078","article-title":"Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections","volume":"22","author":"McFarland","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.gtc.2021.02.010_bib3","doi-asserted-by":"crossref","first-page":"e0167101","DOI":"10.1371\/journal.pone.0167101","article-title":"Highly divergent Clostridium difficile strains isolated from the environment","volume":"11","author":"Janezic","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.gtc.2021.02.010_bib4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s10096-016-2639-3","article-title":"The role of Clostridium difficile in the paediatric and neonatal gut - a narrative review","volume":"35","author":"Lees","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.gtc.2021.02.010_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1473-3099(19)30177-X","article-title":"C difficile-a rose by any other name","volume":"19","author":"The Lancet Infectious Diseases","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2021.02.010_bib6","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1093\/cid\/cis319","article-title":"Current status of Clostridium difficile infection epidemiology","volume":"55","author":"Lessa","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"46","key":"10.1016\/j.gtc.2021.02.010_bib7","doi-asserted-by":"crossref","first-page":"20316","DOI":"10.2807\/ese.17.46.20316-en","article-title":"The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use","volume":"17","author":"Zarb","year":"2012","journal-title":"Euro Surveill"},{"issue":"46","key":"10.1016\/j.gtc.2021.02.010_bib8","doi-asserted-by":"crossref","first-page":"1800516","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800516","article-title":"Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017","volume":"23","author":"Suetens","year":"2018","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.gtc.2021.02.010_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.cmi.2018.12.024","article-title":"Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study","volume":"25","author":"Barbut","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.gtc.2021.02.010_bib10","doi-asserted-by":"crossref","first-page":"O1067","DOI":"10.1111\/1469-0691.12758","article-title":"Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case-control study","volume":"20","author":"Hensgens","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.gtc.2021.02.010_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ajg.2011.398","article-title":"The epidemiology of community-acquired Clostridium difficile infection: a population-based study","volume":"107","author":"Khanna","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2021.02.010_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0924-8579(00)00293-4","article-title":"Treatment and prevention of antibiotic associated diarrhea","volume":"16","author":"Bergogne-B\u00e9r\u00e9zin","year":"2000","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.gtc.2021.02.010_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1075-9964(03)00088-X","article-title":"Clostridium difficile-associated diarrhea from a general hospital in Argentina","volume":"9","author":"Legaria","year":"2003","journal-title":"Anaerobe"},{"issue":"3","key":"10.1016\/j.gtc.2021.02.010_bib14","doi-asserted-by":"crossref","first-page":"e01747-17","DOI":"10.1128\/JCM.01747-17","article-title":"Assessing the burden of Clostridium difficile infection in low- and middle-income countries","volume":"56","author":"Roldan","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.gtc.2021.02.010_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anaerobe.2016.05.006","article-title":"Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection","volume":"41","author":"Ross","year":"2016","journal-title":"Anaerobe"},{"issue":"9759","key":"10.1016\/j.gtc.2021.02.010_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(10)61266-4","article-title":"Clostridium difficile infection in Europe: a hospital-based survey","volume":"377","author":"Bauer","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.gtc.2021.02.010_bib17","doi-asserted-by":"crossref","first-page":"e0176797","DOI":"10.1371\/journal.pone.0176797","article-title":"The emergence of Clostridium difficile infection in Asia: a systematic review and meta-analysis of incidence and impact","volume":"12","author":"Borren","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.gtc.2021.02.010_bib18","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10096-012-1587-9","article-title":"Underestimation of Clostridium difficile infection among clinicians: an international survey","volume":"31","author":"Mavros","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.gtc.2021.02.010_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.anaerobe.2018.01.011","article-title":"Clostridioides (Clostridium) difficile infection in hospitalized patients with antibiotic-associated diarrhea: a systematic review and meta-analysis","volume":"50","author":"Nasiri","year":"2018","journal-title":"Anaerobe"},{"issue":"18","key":"10.1016\/j.gtc.2021.02.010_bib20","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","article-title":"Host and pathogen factors for Clostridium difficile infection and colonization","volume":"365","author":"Loo","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.gtc.2021.02.010_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2217\/17460913.3.5.563","article-title":"Antibiotic-associated diarrhea: epidemiology, trends and treatment","volume":"3","author":"McFarland","year":"2008","journal-title":"Future Microbiol"},{"issue":"4","key":"10.1016\/j.gtc.2021.02.010_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1075-9964(03)00119-7","article-title":"Clostridium difficile and enterotoxigenic Bacteroides fragilis strains isolated from patients with antibiotic associated diarrhoea","volume":"9","author":"Pituch","year":"2003","journal-title":"Anaerobe"},{"issue":"8","key":"10.1016\/j.gtc.2021.02.010_bib23","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5812\/ircmj.5189","article-title":"Antimicrobial susceptibility of clostridium difficile clinical isolates in Iran","volume":"15","author":"Goudarzi","year":"2013","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.gtc.2021.02.010_bib24","doi-asserted-by":"crossref","first-page":"916826","DOI":"10.1155\/2014\/916826","article-title":"Clostridium difficile infection: epidemiology, pathogenesis, risk factors, and therapeutic options","volume":"2014","author":"Goudarzi","year":"2014","journal-title":"Scientifica"},{"issue":"6","key":"10.1016\/j.gtc.2021.02.010_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anaerobe.2009.09.002","article-title":"Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections","volume":"15","author":"McFarland","year":"2009","journal-title":"Anaerobe"},{"issue":"7","key":"10.1016\/j.gtc.2021.02.010_bib26","doi-asserted-by":"crossref","first-page":"e1005758","DOI":"10.1371\/journal.ppat.1005758","article-title":"CdtR regulates TcdA and TcdB production in Clostridium difficile","volume":"12","author":"Lyon","year":"2016","journal-title":"PLoS Pathog"},{"issue":"23","key":"10.1016\/j.gtc.2021.02.010_bib27","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa051590","article-title":"An epidemic, toxin gene-variant strain of Clostridium difficile","volume":"353","author":"McDonald","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.gtc.2021.02.010_bib28","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.gtc.2021.02.010_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1056\/NEJM198901263200402","article-title":"Nosocomial acquisition of Clostridium difficile infection","volume":"320","author":"McFarland","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.gtc.2021.02.010_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/clinids\/18.2.181","article-title":"Clostridium difficile colonization and diarrhea at a tertiary care hospital","volume":"18","author":"Samore","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.gtc.2021.02.010_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/infdis\/143.1.51","article-title":"Studies on the epidemiology of colitis due to Clostridium difficile in hamsters","volume":"143","author":"Toshniwal","year":"1981","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.gtc.2021.02.010_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0002-9343(85)90460-7","article-title":"Clinical and endoscopic findings in patients early in the course of Clostridium difficile-associated pseudomembranous colitis","volume":"78","author":"Gebhard","year":"1985","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.gtc.2021.02.010_bib33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.SMJ.0000054537.20978.D4","article-title":"Leukemoid reactions complicating colitis due to Clostridium difficile","volume":"97","author":"Marinella","year":"2004","journal-title":"South Med J"},{"key":"10.1016\/j.gtc.2021.02.010_bib34","first-page":"487","article-title":"Clinical spectrum & pathogenesis of Clostridium difficile associated diseases","volume":"131","author":"Vaishnavi","year":"2010","journal-title":"Indian J Med Res"},{"issue":"8","key":"10.1016\/j.gtc.2021.02.010_bib35","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/521854","article-title":"Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents","volume":"45","author":"Riggs","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gtc.2021.02.010_bib36","doi-asserted-by":"crossref","first-page":"l4609","DOI":"10.1136\/bmj.l4609","article-title":"Clostridioides difficile: diagnosis and treatments","volume":"366","author":"Guery","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.gtc.2021.02.010_bib37","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/cid\/cit286","article-title":"Does empirical Clostridium difficile infection (CDI) therapy result in false-negative CDI diagnostic test results?","volume":"57","author":"Sunkesula","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.gtc.2021.02.010_bib38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.idc.2019.02.010","article-title":"Clostridioides difficile infection in the stem cell transplant and hematologic malignancy population","volume":"33","author":"Misch","year":"2019","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"10.1016\/j.gtc.2021.02.010_bib39","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JCM.00427-10","article-title":"Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches","volume":"48","author":"Tenover","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"12","key":"10.1016\/j.gtc.2021.02.010_bib40","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1469-0691.2009.03098.x","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI)","volume":"15","author":"Crobach","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.gtc.2021.02.010_bib41","first-page":"371","article-title":"Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991","volume":"15","author":"Olson","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"10.1016\/j.gtc.2021.02.010_bib42","doi-asserted-by":"crossref","first-page":"ITC49","DOI":"10.7326\/AITC201810020","article-title":"Clostridioides difficile infection","volume":"169","author":"Guh","year":"2018","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.gtc.2021.02.010_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2021.02.010_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection","volume":"20","author":"Debast","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.gtc.2021.02.010_bib45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A\u00a0comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.gtc.2021.02.010_bib46","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.gtc.2021.02.010_bib47","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1503\/cmaj.1041104","article-title":"Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity","volume":"171","author":"P\u00e9pin","year":"2004","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.gtc.2021.02.010_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archsurg.2009.51","article-title":"Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality","volume":"144","author":"Sailhamer","year":"2009","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.gtc.2021.02.010_bib49","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1517\/13543784.17.4.547","article-title":"OPT-80, a macrocyclic antimicrobial agent for the treatment of Clostridium difficile infections: a review","volume":"17","author":"Gerber","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2021.02.010_bib50","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1093\/cid\/cis339","article-title":"Antimicrobial activities of fidaxomicin","volume":"55","author":"Goldstein","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2021.02.010_bib51","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1093\/cid\/cis338","article-title":"Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI","volume":"55","author":"Louie","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.gtc.2021.02.010_bib52","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/cid\/cir830","article-title":"Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection","volume":"54","author":"Venugopal","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.gtc.2021.02.010_bib53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","author":"Cornely","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.gtc.2021.02.010_bib54","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.gtc.2021.02.010_bib55","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2012.45.5899","article-title":"Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin","volume":"31","author":"Cornely","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.gtc.2021.02.010_bib56","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2146\/ajhp170554","article-title":"Cost-effectiveness analysis of initial treatment strategies for mild-to-moderate Clostridium difficile infection in hospitalized patients","volume":"75","author":"Ford","year":"2018","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"10.1016\/j.gtc.2021.02.010_bib57","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1017\/ice.2018.139","article-title":"Cost-effectiveness of three different strategies for the treatment of first recurrent Clostridium difficile infection diagnosed in a community setting","volume":"39","author":"Lam","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.gtc.2021.02.010_bib58","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/cid\/civ409","article-title":"The addition of intravenous metronidazole to oral vancomycin is associated with improved mortality in critically ill patients with Clostridium difficile infection","volume":"61","author":"Rokas","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.gtc.2021.02.010_bib59","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/ajg.2014.80","article-title":"Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection","volume":"109","author":"Saffouri","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2021.02.010_bib60","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/apt.14201","article-title":"Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection","volume":"46","author":"Quraishi","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"17","key":"10.1016\/j.gtc.2021.02.010_bib61","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/jama.2015.3725","article-title":"Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C.\u00a0difficile infection: a randomized clinical trial","volume":"313","author":"Gerding","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.gtc.2021.02.010_bib62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/cid\/ciw731","article-title":"Oral vancomycin followed by fecal transplantation versus tapering oral vancomycin treatment for recurrent Clostridium difficile infection: an open-label, randomized controlled trial","volume":"64","author":"Hota","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.gtc.2021.02.010_bib63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/infdis\/jiv766","article-title":"A\u00a0novel microbiome therapeutic increases gut microbial diversity and prevents recurrent Clostridium difficile infection","volume":"214","author":"Khanna","year":"2016","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.gtc.2021.02.010_bib64","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/cid\/civ938","article-title":"Safety and durability of RBX2660 (Microbiota Suspension) for recurrent Clostridium difficile infection: results of the PUNCH CD study","volume":"62","author":"Orenstein","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.gtc.2021.02.010_bib65","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12916-016-0680-9","article-title":"Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection","volume":"14","author":"Youngster","year":"2016","journal-title":"BMC Med"},{"issue":"9251","key":"10.1016\/j.gtc.2021.02.010_bib66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(00)03592-3","article-title":"Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea","volume":"357","author":"Kyne","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gtc.2021.02.010_bib67","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa1602615","article-title":"Bezlotoxumab for prevention of recurrent Clostridium difficile infection","volume":"376","author":"Wilcox","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2021.02.010_bib68","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/523341","article-title":"Probiotics: definition, sources, selection, and uses","volume":"46","author":"Sanders","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.gtc.2021.02.010_bib69","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1572-0241.2006.00465.x","article-title":"Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease","volume":"101","author":"McFarland","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2021.02.010_bib70","article-title":"Probiotics for treatment of Clostridium difficile-associated colitis in adults","author":"Pillai","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gtc.2021.02.010_bib71","first-page":"27","article-title":"Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis","volume":"9","author":"Lau","year":"2016","journal-title":"Int J Gen Med"},{"issue":"1","key":"10.1016\/j.gtc.2021.02.010_bib72","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jac\/dku324","article-title":"SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in\u00a0vitro gut model","volume":"70","author":"Baines","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.gtc.2021.02.010_bib73","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jac\/dkv006","article-title":"In\u00a0vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C.\u00a0difficile","volume":"70","author":"Corbett","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.gtc.2021.02.010_bib74","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/AAC.02184-13","article-title":"Comparative in\u00a0vitro activities of SMT19969, a new antimicrobial agent, against 162 strains from 35 less frequently recovered intestinal Clostridium species: implications for Clostridium difficile recurrence","volume":"58","author":"Goldstein","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.gtc.2021.02.010_bib75","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1128\/AAC.01136-13","article-title":"Comparative in\u00a0vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates","volume":"57","author":"Goldstein","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.gtc.2021.02.010_bib76","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1473-3099(17)30235-9","article-title":"Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study","volume":"17","author":"Vickers","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.gtc.2021.02.010_bib77","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.anaerobe.2019.04.010","article-title":"Current and future trends in clostridioides (clostridium) difficile infection management","volume":"58","author":"Khanna","year":"2019","journal-title":"Anaerobe"},{"issue":"5","key":"10.1016\/j.gtc.2021.02.010_bib78","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jac\/dkm014","article-title":"Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series","volume":"59","author":"Fowler","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"Suppl 4","key":"10.1016\/j.gtc.2021.02.010_bib79","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ajt.12097","article-title":"Clostridium difficile infections in solid organ transplantation","volume":"13","author":"Dubberke","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.gtc.2021.02.010_bib80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1086\/524333","article-title":"Prospective, controlled, cross-over trial of alcohol-based hand gel in critical care units","volume":"29","author":"Rupp","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"10.1016\/j.gtc.2021.02.010_bib81","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/502596","article-title":"Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub","volume":"26","author":"Gordin","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.gtc.2021.02.010_bib82","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/669521","article-title":"Effectiveness of hand hygiene for removal of Clostridium difficile spores from hands","volume":"34","author":"Edmonds","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"10.1016\/j.gtc.2021.02.010_bib83","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1128\/JCM.00165-06","article-title":"Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus","volume":"44","author":"Asha","year":"2006","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.gtc.2021.02.010_bib84","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12879-015-0869-0","article-title":"Prevalence and management of antibiotic associated diarrhea in general hospitals","volume":"15","author":"Elseviers","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.gtc.2021.02.010_bib85","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/519178","article-title":"Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital","volume":"28","author":"Chang","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.gtc.2021.02.010_bib86","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/528813","article-title":"Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005","volume":"29","author":"Kutty","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.gtc.2021.02.010_bib87","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jhin.2013.02.019","article-title":"Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial","volume":"84","author":"Selinger","year":"2013","journal-title":"J\u00a0Hosp Infect"},{"issue":"9","key":"10.1016\/j.gtc.2021.02.010_bib88","doi-asserted-by":"crossref","first-page":"e13564","DOI":"10.1111\/ctr.13564","article-title":"Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: guidelines from the American Society of Transplantation Community of Practice","volume":"33","author":"Mullane","year":"2019","journal-title":"Clin Transplant"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855321000224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855321000224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:29:55Z","timestamp":1760178595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855321000224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0889855321000224"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2021.02.010","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2021.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}